Table 7.
Bleeding complications of percutaneous native kidney biopsies in nephrology facilities for adult patients
| Year | 2015 | 2016 | 2017 | Total |
|---|---|---|---|---|
| Number of facilities | 112 | 114 | 117 | 343 |
| Number of biopsies | 4906 | 5192 | 5559 | 15,657 |
| Macroscopic hematuria with no treatment (%) | 132 (2.7) | 136 (2.6) | 163 (2.9) | 431 (2.8) |
| Bleeding complications with treatment (%) | 58 (1.2) | 50 (1.0) | 59 (1.1) | 167 (1.1) |
| Erythrocyte transfusiona (%) | 38 (0.8) | 39 (0.8) | 44 (0.8) | 121 (0.8) |
| Surgical hemostasisa (%) | 1 (0.02) | 0 (0) | 0 (0.0) | 1 (0.006) |
| Transcatheter arterial embolizationa (%) | 14 (0.3) | 8 (0.2) | 9 (0.2) | 31 (0.2) |
| Bladder lavagea (%) | 21 (0.4) | 15 (0.3) | 20 (0.4) | 56 (0.4) |
| Nephrectomya (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Death from severe bleedinga (%) | 0 (0) | 0 (0) | 1 (0.02) | 1 (0.006) |
aMultiple selections allowed in the same biopsy